Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
PharmaVentures acts as exclusive M&A advisor to the PE firm capiton AG on the successful sale of MiP Pharma's Sterile Production Facility to FAMAR Group
-
Customer Drop-Offs Cut by 35% With Sumsub's New Travel Rule SDK For Crypto Apps
-
Tashkent International Investment Forum 2025 Unveils Official Partners as New Uzbekistan: The Big Country with Big Opportunities Continues FDI Drive
-
Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan
-
SPEC Resumes Global Collaboration with Companies on U.S. BIS Entity List
-
Creative Tech Textile's Seawool® Opens New Horizons for Sustainable Fashion
-
Morrisons Daily Extends Relationship with NCR Atleos, Further Expanding Self-Service Cash Access
-
FICO UK Credit Card Market Report: March 2025
-
SentinelOne Wins Best Security Company at the 2025 SC Awards Europe
-
Symetra Investment Management Goes Live with Allvue Systems CLO Solution
-
U.S. SMBs Say Payment Innovation Is Key Driver of Growth
-
Philips announces exchange ratio for 2024 dividend
-
UMC Reports Sales for May 2025
-
GKN Automotive continues to drive progress towards its net zero 2045 target
-
TISSIUM selected for the French Tech 120 Program
-
Share Buyback Transaction Details May 29 – June 4, 2025
-
Philips announces exchange ratio for 2024 dividend
-
Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan
-
Oculis Publishes Results of 2025 Annual General Meeting
-
Enko Capital welcomes commitment from IFC to new Impact Credit Fund
-
Capgemini becomes an Official Partner of the Tour de France and Tour de France Femmes avec Zwift until 2029 to power cycling through tech and innovation
-
MegazoneCloud Named Snowflake Growth Partner of the Year for APJ
-
Early Closure of Subscription Process for 3rd Tranche of UAB "Kvartalas" Bonds
-
Colle AI Expands Solana Infrastructure to Scale Creator-Led NFT Innovation
-
Hengrui Pharma Showcases Global Impact at the 2025 ASCO: 72 Study Results Highlight Chinese Cancer Innovation
-
MEXC Drives Stablecoin Expansion After $20M USDe Purchase and $100M TVL Milestone
-
Cheema Hire: Revolutionizing Equipment Rental in Sydney with Quality, Affordability, and Community Focus
-
UPMC Ireland Selects MEDITECH Expanse as the Cornerstone of its Digital Strategy
-
KBRA Releases Research – UK Mortgage and Housing Trends: June 2025 Update
-
AI Search Optimization: Google AI Overviews (AIO) & Hybrid SEO Services Launched
-
Mario Kart World Launching Today
-
Form 8.5 (EPT/RI) - De La Rue plc
-
Form 8.5 (EPT/RI) - Dowlais Group plc
-
Reliable market tools enhance trading precision
-
Form 8.5 (EPT/RI) - Thruvision Group plc
-
EXKLUSIV: Deutsche Institutionen unterstuetzen Stoxira stillschweigend als sicheren Hafen inmitten globaler KryptoTurbulenzen
-
A Comprehensive Guide to Effective Mental Health and Addiction Treatment Options
-
P2P Group Announces Exclusive Quantum Security Capability and Breakthrough Capabilities
-
Form 8.5 (EPT/RI) - Craneware plc
-
OAK Physio & Wellness Opens Flagship Mississauga Clinic, Bringing Evidence-Based Rehab to the Heart of the City
-
Largest Ever Land Back-Conservation Deal in Calif. Now Complete: Western Rivers Conservancy Conveys Final Acreage to Yurok Tribe in a 47,000-Acre Effort Critical to the Salmon, Wildlife and Forests of
-
Hello Group Inc. Announces Unaudited Financial Results for the First Quarter of 2025
-
Inspiration Energy Announces DTC Eligibility and Upcoming Exploration Near Ramp Metals Discovery in Saskatchewan
-
CancerVax Achieves Major Milestone with Successful Creation of Cell Targeting Nanoparticle
-
Villas of Distinction® Reveals Why Now Is the Best Time to Book Italy
-
NEUBERGER BERMAN RAISES $4 BILLION FOR LATEST GP-LED SECONDARY FUND, MARKING ONE OF THE LARGEST RAISES IN A RAPIDLY GROWING MARKET
-
Matalan Partners With Toshiba Global Commerce Solutions to Enhance In-Store Experience
-
Ryan Expands Reach in United Kingdom with Acquisition of Inspired Corporate Advisory
-
Municipality Finance issues NOK 2 billion notes under its MTN programme
-
Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)
